These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 15816506
1. Two patterns of ion channelopathy in the myocardium: perspectives for development of anti-arrhythmic agents. Dai DZ. Curr Opin Investig Drugs; 2005 Mar; 6(3):289-97. PubMed ID: 15816506 [Abstract] [Full Text] [Related]
2. Ion channelopathy and hyperphosphorylation contributing to cardiac arrhythmias. Dai DZ, Yu F. Acta Pharmacol Sin; 2005 Aug; 26(8):918-25. PubMed ID: 16038623 [Abstract] [Full Text] [Related]
3. Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure. Ai X, Curran JW, Shannon TR, Bers DM, Pogwizd SM. Circ Res; 2005 Dec 09; 97(12):1314-22. PubMed ID: 16269653 [Abstract] [Full Text] [Related]
4. [Function and role of the sarcoplasmic reticulum in heart disease]. Reyes-Juárez JL, Zarain-Herzberg A. Arch Cardiol Mex; 2006 Dec 09; 76 Suppl 4():S18-32. PubMed ID: 17469332 [Abstract] [Full Text] [Related]
5. The ryanodine receptor from canine heart sarcoplasmic reticulum is associated with a novel FK-506 binding protein. Timerman AP, Jayaraman T, Wiederrecht G, Onoue H, Marks AR, Fleischer S. Biochem Biophys Res Commun; 1994 Jan 28; 198(2):701-6. PubMed ID: 8297381 [Abstract] [Full Text] [Related]
6. Phospholamban: a key determinant of cardiac function and dysfunction. Rodriguez P, Kranias EG. Arch Mal Coeur Vaiss; 2005 Dec 28; 98(12):1239-43. PubMed ID: 16435604 [Abstract] [Full Text] [Related]
8. The sarcoplasmic reticulum Ca2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states. Zucchi R, Ronca-Testoni S. Pharmacol Rev; 1997 Mar 28; 49(1):1-51. PubMed ID: 9085308 [No Abstract] [Full Text] [Related]
9. Induced ion currents and the endothelin pathway as targets for anti-arrhythmic agents. Dai DZ, Dai Y. Curr Opin Investig Drugs; 2008 Sep 28; 9(9):1001-8. PubMed ID: 18729007 [Abstract] [Full Text] [Related]
11. Ryanodine receptor-targeted anti-arrhythmic therapy. Wehrens XH, Lehnart SE, Marks AR. Ann N Y Acad Sci; 2005 Jun 28; 1047():366-75. PubMed ID: 16093511 [Abstract] [Full Text] [Related]
12. Something old, something new: changing views on the cellular mechanisms of heart failure. Sipido KR, Eisner D. Cardiovasc Res; 2005 Nov 01; 68(2):167-74. PubMed ID: 16202399 [No Abstract] [Full Text] [Related]
13. Vulnerable substrate and multiple ion channel disorder in a diseased heart will be new targets for antiarrhythmic therapy. Dai DZ. Acta Pharmacol Sin; 2000 Apr 01; 21(4):289-95. PubMed ID: 11324452 [Abstract] [Full Text] [Related]
14. [Sarcoplasmic reticulum function and heart failure: a novel therapeutic target for heart failure]. Minamisawa S, Ikeda Y. Clin Calcium; 2006 Jan 01; 16(1):37-44. PubMed ID: 16397349 [Abstract] [Full Text] [Related]
15. Intermolecular conformational coupling and free energy exchange enhance the catalytic efficiency of cardiac muscle SERCA2a following the relief of phospholamban inhibition. Mahaney JE, Albers RW, Waggoner JR, Kutchai HC, Froehlich JP. Biochemistry; 2005 May 31; 44(21):7713-24. PubMed ID: 15909986 [Abstract] [Full Text] [Related]
16. Gender differences in the modulation of cardiac gene expression by dietary conjugated linoleic acid isomers. Tappia PS, Dent MR, Aroutiounova N, Babick AP, Weiler H. Can J Physiol Pharmacol; 2007 May 31; 85(3-4):465-75. PubMed ID: 17612656 [Abstract] [Full Text] [Related]
17. Abnormal ryanodine receptor function in heart failure. Yano M, Yamamoto T, Ikemoto N, Matsuzaki M. Pharmacol Ther; 2005 Sep 31; 107(3):377-91. PubMed ID: 15951021 [Abstract] [Full Text] [Related]
18. Control of muscle ryanodine receptor calcium release channels by proteins in the sarcoplasmic reticulum lumen. Beard NA, Wei L, Dulhunty AF. Clin Exp Pharmacol Physiol; 2009 Mar 31; 36(3):340-5. PubMed ID: 19278523 [Abstract] [Full Text] [Related]
19. Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation. El-Armouche A, Boknik P, Eschenhagen T, Carrier L, Knaut M, Ravens U, Dobrev D. Circulation; 2006 Aug 15; 114(7):670-80. PubMed ID: 16894034 [Abstract] [Full Text] [Related]
20. Calcium-transporters in myocardial cells. Subramani S, Subbanna PK. Indian J Physiol Pharmacol; 2006 Aug 15; 50(2):99-113. PubMed ID: 17051729 [Abstract] [Full Text] [Related] Page: [Next] [New Search]